Enhanced expression of epidermal growth factor receptor correlates with alterations of chromosome 7 in human pancreatic cancer

M. Korc, P. Meltzer, J. Trent

Research output: Contribution to journalArticlepeer-review

169 Scopus citations

Abstract

Recently, the gene for the epidermal growth factor (EGF) receptor has been mapped to chromosome 7p, the short arm of chromosome 7 [Shimizu, N., Kondo, I., Gamou, M.A., Behzadian, A. & Shimizu, Y. (1984) Somatic Cell Mol. Genet. 10, 45-53]. Utilizing EGF binding in saturation studies, karyology, and cDNA hybridization experiments, we have sought to determine whether there is a correlation between dosage or alteration of chromosome 7 and enhanced expression of EGF receptor in cultured human pancreatic carcinoma cells. Saturation binding studies with 125I-labeled EGF were performed at 4°C with four established human pancreatic cancer cell lines: T3M4, PANC-1, COLO 357, and UACC-462. Analysis of binding data revealed enhanced numbers of EGF receptors in all four cell lines. Chromosome banding analysis revealed clonal structural alterations of EGF chromosome 7p in the cell lines T3M4, PANC-1 and COLO 357, whereas UACC-462 displayed multiple copies of chromosome 7. Hybridization studies using a radiolabeled EGF receptor cDNA probe failed to demonstrate DNA sequence amplification in any cell line but confirmed the presence of EGF receptor mRNA in these cells in approximate proportion to EGF receptor number. Our results suggest that enhanced expression of EGF receptor in human pancreatic cancer can be associated with either structural or numerical alterations of chromosome 7.

Original languageEnglish (US)
Pages (from-to)5141-5144
Number of pages4
JournalProceedings of the National Academy of Sciences of the United States of America
Volume83
Issue number14
DOIs
StatePublished - 1986

ASJC Scopus subject areas

  • General

Fingerprint Dive into the research topics of 'Enhanced expression of epidermal growth factor receptor correlates with alterations of chromosome 7 in human pancreatic cancer'. Together they form a unique fingerprint.

Cite this